✨ 5 results found - Searched 23332 records in 2ms.
Disertasi
Pengeditan ekson 2 gen survivin menggunakan sistem CRISPR/Cas9 dalam menurunkan agresivitas kanker: Kajian studi in vitro pada galur sel kanker payudara triple negative BT549 dan studi preliminary in vivo pada tikus dengan induksi DMBA
2025 | BY Resda Akhra Syahrani - Septelia Inawati Wanandi - Melva Louisa - Puspita Eka Wuyung- Survivin exon 2 genome editing using CRISPR/Cas9 system for cancer aggressiveness attenuation: In vitro study on triple negative breast cancer cell line BT549 and in vivo study on DMBA induced rat.
- Nomor Panggil D25020fk
Disertasi
Pengembangan Model Probabilitas Respons Akhir Terapi Radiasi Kanker Serviks Stadium Lanjut Menggunakan Parameter Apparent Diffusion Coefficient dan T2 Tumor pada Magnetic Resonance Imaging: Kaitannya Dengan Ekspresi Survivin
2025 | BY Trifonia Pingkan Siregar - Fitriyadi Kusuma - Sawitri Darmiati - Septelia Inawati Wanandi- Development of Probability Model for Final Response to Advanced Stage Cervical Cancer Therapy using Apparent Diffusion Coefficient and T2 Tumour Parameter on Magnetic Resonance Imaging: Associated with Survivin Expression.
- Nomor Panggil D25011fk
Disertasi
Kadar Survivin, Telomerase, dan Sitokrom C sebagai Prediktor Respons Terapi pada Pasien Karsinoma Sel Skuamosa Serviks Stadium IIIB.
2017 | BY ANDRIJONO - Ani Retno Prijanti - Laila Nuranna - Fitriyadi Kusuma- Levels of Survivin, Telomerase, and Cytochrome C as Predictor of Therapeutic Response in Patients with Stage IIIB Squamous Cell Carcinoma of Cervix.
- Nomor Panggil D17022fk
Skripsi
The effect of different intervals of hypoxia on the level of survivin gene expression in breast cancer stem cells CD44+/CD24-
2016 | BY Jessica Halim - Septelia Inawari Wanandi- Pengaruh durasi hypoxia yang berbeda terhadap ekspresi gen survivin pada sel punca kanker payudara CD44+/CD24 .
- Nomor Panggil S16196fk
Tesis
Studi in silico dan in vitro senyawa bahan alam untuk terapi target sel punca kanker payudara manusia asal Indonesia
2015 | BY Agung Heru Wibowo - Agus Limanto - Septelia Inawati Wanandi- In silico and In vitro studies of natural active compound for therapeutic target of human breast cancer stem cells from Indonesia.
- Nomor Panggil T15353FK